Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

32 results about "Laminitis" patented technology

Laminitis is a disease that affects the feet of ungulates and is found mostly in horses and cattle. Clinical signs include foot tenderness progressing to inability to walk, increased digital pulses, and increased temperature in the hooves. Severe cases with outwardly visible clinical signs are known by the colloquial term founder, and progression of the disease will lead to perforation of the coffin bone through the sole of the hoof or being unable to stand up requiring euthanasia.

Compositions and Methods for Treating and Preventing Inflammatory and/or Degenerative Processes in Humans and Other Animals

InactiveUS20080317885A1Salicyclic acid active ingredientsBiocideReactive airway diseaseSarcoidosis
Disclosed are compositions useful for treating Alzheimer's disease, atherosclerosis, arteriosclerosis, osteoarthritis and other degenerative joint diseases, Huntington's chorea, Parkinson's disease, optic atrophy, retinitis pigmentosa, macular degeneration, muscular dystrophy, aging-associated degenerative processes, asthma, dermatitis, laminitis, pemphigoid, pemphigus, reactive airway disease (e.g., COPD, IAD), inflammatory bowel disease (e.g., Crohn's disease, ulcerative colitis), multiple sclerosis, rheumatoid arthritis, periodontal disease, systemic lupus erythematosus, sarcoidosis, psoriasis, type I diabetes, ischemia-reperfusion injury, chronic inflammatory diseases, geriatric wasting, cancer cachexia, cachexia associated with chronic inflammation, sick feeling syndrome, and other inflammatory and/or degenerative diseases, disorders, conditions, and processes in humans and other animals. In one embodiment, the compositions include at least 4 of the following: a MMP1 inhibitor, a MMP2 inhibitor, a MMP3 inhibitor, a MMP7 inhibitor, a MMP9 inhibitor, an ADAMTS-4 inhibitor, a MMP13 inhibitor, and a MMP14 inhibitor. In another embodiment, the compositions include a curcuminoid, a polymethoxylated flavone, a catechin, and a boswellic acid.
Owner:BAKER DONALD J

Immunogen adherence inhibitor directed to lactic acid producing organisms and method of making and using it

A microbial adherence inhibitor specific to lactic acid producing microorganisms, in the form of fowl egg antibodies is disclosed, along with the method of making it and methods of using it. The inhibitor functions by substantially preventing the attachment or adherence of colony-forming immunogens in the rumen and intestinal tracts of host food animals. The inhibitor is made by inoculating female birds with the immunogen, allowing time for an immune response in the female bird and then harvesting the eggs that contain antibodies to the immunogen. The egg contents can be dried or used as a liquid and added to the feed or water for the host animals. Dependent upon the particular immunogen with which the female bird is inoculated, the egg antibody is used to promote the growth of food animals by improving feed conversion rates by decreasing the lactic acid production caused by the presence of certain colony-forming organisms in the animals, and to substantially reduce or eliminate the incidence of species that have been linked to very high production of lactic acid which can result in reduced performance and in acute situations, dangerously low rumen pH levels. When high levels of lactic acid are present in the rumen, rumen ulcers can form. When rumen ulcers are present other bacteria such as Fusobacterium necrophorum can escape the rumen and cause liver abscesses or laminitis, which further reduce feed conversion efficiency. Colony forming immunogens such as Streptococcus bovis (a major lactic acid producer) and Fusobacterium necrophorum can both be targeted by antibodies to enhance feed efficiency.
Owner:NASH PETER +1

Veterinary medicine for treating animal digestive tract diseases

The invention discloses a veterinary medicine for treating animal digestive tract diseases, which is characterized by consisting of the following Chinese herbal medicinal ingredients in part by weight: medicated leaven, roasted malt, stir-fried hawthorn, atractylodes lancea, officinal magnolia bark, dried ginger, liquorice, green tangerine peel, tangerine peel, rhubarb, sophora flavescens and Laimingzi. A preparation method of the veterinary medicine comprises the following steps: after strictly purchasing the traditional Chinese medicine on selection, air-drying or drying; grinding and sieving the powder by an 80-mesh sieve carrying out subpackaging by double-layer plastic bags according to the specification of 500g per bag. The veterinary medicine for treating the animal digestive tract diseases, which is disclosed by the invention, has curative effects of resolving phlegm, clearing away heat, helping digestion and removing accumulation, clearing the hollow viscera, assisting in digesting, eliminating food retention and relieving stagnant qi and relieving intestines and has very satisfied curative effects on gastrointestinal indigestion, food-induced laminitis, impairment and diarrhea which are caused by overeating and the like, which are caused by excessive concentrates. The veterinary medicine also can be used for treating the same symptoms of other animals.
Owner:QINGDAO AGRI UNIV

A compound traditional Chinese medicine buccal tablet for nourishing blood and replenishing qi and its preparation process

The invention discloses a blood-enriching and qi-tonifying compound traditional chinese lozenge and a preparation technology thereof. The blood-enriching and qi-tonifying compound traditional chinese lozenge mainly comprises bighead atractylodes rhizome, jujube, fleece-flower root, dioscorea fordii prain et burkill, jujube kernel, tuber of dwarf lilyturf, radix codonopsis, matrimony vine, alpinia officinarum hance, common fennel fruit, white peony root, semen litchi, poria cocos, pine kernel, chinese cassia tree, radix astragali, chinese angelica, ligusticum wallichii, red sage root, fructus trichosanthis, and immature bitter orange. The above raw materials are subjected to the traditional preparation process to form the lozenge. The blood-enriching and qi-tonifying compound traditional Chinese lozenge has no toxic or side effect and is scientific in compatibility and good in synergistic effect. Therefore, the blood-enriching and qi-tonifying compound traditional Chinese lozenge has the efficacies of invigorating spleen and benefiting lung, thus being suitable for the symptomatic treatment on various symptoms caused by the deficiency of qi and blood. Meanwhile, the symptoms of dizziness, tinnitus, laminitis, soreness of waist, back pain, insomnia, dreaminess, palpitations, shortness of breath, eupyrexia of hand centre and sole centre, skin dim and reluster are relieved. In addition, the lozenge prepared by the above method is reasonable in formula, simple in preparation process and good in molding effect. The bitter taste of the compound traditional Chinese lozenge is covered up by menthol, so that the compound traditional Chinese lozenge is good in mouthfeel. Therefore, the compound traditional Chinese lozenge is very convenient to take for people.
Owner:ZHUHAI COLLEGE OF JILIN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products